跳至主要内容
临床试验/NCT02821117
NCT02821117已完成不适用

An Evaluation of Self-Management of Diabetes Using FreeStyle Libre Flash Glucose Monitoring System in Young People

Abbott Diabetes Care20 个研究点 分布在 3 个国家目标入组 76 人开始时间: 2016年6月30日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
76
试验地点
20
主要终点
Change in Time in Range

研究概览

简要总结

The study is designed to determine glycaemic control achieved using the FreeStyle Libre Flash Glucose Monitoring System (FreeStyle Libre) versus Self-Monitoring Blood Glucose (SMBG) for the self-management of diabetes.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Other
盲法
None

入排标准

年龄范围
4 Years 至 17 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Aged ≥4 years and ≤17 years.
  • Has an identified Caregiver of ≥18 years.
  • Type 1 diabetes using insulin (administered by injections or CSII) for at least 1 year.
  • Current insulin regimen has been unchanged for at least 2 months prior to enrolment (e.g. change of insulin or administration method), with no plans to change insulin regimen.
  • Currently testing BG, on average at least 2 times per day.

排除标准

  • Concomitant disease or condition that may compromise patient safety including and not limited to; cystic fibrosis, severe mental illness, known or suspected eating disorder or any uncontrolled long term medical condition.
  • Currently prescribed oral steroid therapy for any acute or chronic condition (or requires it during the study).
  • Currently receiving dialysis treatment or planning to receive dialysis during the study.
  • Female participant known to be pregnant.
  • Participating in another device or drug study that could affect glucose measurements or glucose management.
  • Currently using or planning to use FreeStyle Libre Flash Glucose Monitoring System or a Continuous Glucose Monitoring (CGM) device during the study.
  • Has used the FreeStyle Libre Flash Glucose Monitoring System or a Continuous Glucose Monitoring (CGM) device in the previous 3 months.
  • Known (or suspected) allergy to medical grade adhesives.
  • In the investigator's opinion the participant is unsuitable to participate due to any other cause/reason (participant and caregiver considered).

结局指标

主要结局

Change in Time in Range

时间窗: Baseline and days 56 to 70

Time in range (Sensor glucose 3.9-10.0 mmol/L \[70-180 mg/dL\]) in days 56-70 minus time in range at baseline (days 1-15).

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (20)

Loading locations...

相似试验